跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
碳酸氢钠血滤置换液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Hemofiltration Replacement Fluid of Sodium Bicarbonate
Approved
化学药品
Hemofiltration Replacement Fluid of Sodium Bicarbonate
Baxter Holding BV
🇨🇳 National Medical Products Administration
Approval Date
May 18, 2022
Approval ID
8GXWaeMWagL
Company
Baxter Holding BV
Type
化学药品
Approval Details
Approval Id
8GXWaeMWagL
Approval Number
国药准字HJ20220049
Generic Name
碳酸氢钠血滤置换液
Generic Name En
Hemofiltration Replacement Fluid of Sodium Bicarbonate
Drug Type
化学药品
Dosage Form
注射剂
Strength
5000ml
Reg Date
2022-05-18
Expired Date
2027-05-17
Company Name
Baxter Holding BV
Production Company Name
BIEFFE MEDITAL SPA
Company Detail Path
/organization/baxter-holding-bv
Production Company Detail Path
/organization/bieffe-medital-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 18, 2022
Approval ID
8GXWaeMWagL
Type
化学药品
Back to NMPA Approvals
